Ignacio Musé

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

Gilberto Schwartsmann, Holger J. Schünemann, Chistopher Gorini et al. · Investigational New Drugs · 2000 · 111 citations

Medicine, Oncology, Pharmacology +13

Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR

Nora Berois, Mario Varangot, Bemardo M. Aizen et al. · European Journal of Cancer · 2000 · 105 citations

Medicine, Molecular Biology, Oncology +14

Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative

Cheng Har Yip, Eduardo Cazap, Benjamin O. Anderson et al. · The Breast · 2011 · 61 citations · Full text

Medicine, Oncology, Radiology +17

Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer

Glòria Roldán, Lucı́a Delgado, Ignacio Musé · Cancer Biology & Therapy · 2006 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +12

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

Lucı́a Delgado, Gina E. Fernandez, G. Grotiuz et al. · Breast Cancer Research and Treatment · 2010 · 25 citations

Medicine, Genetics, Oncology +14